• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

γ-干扰素诱导蛋白-10 与慢性丙型肝炎:与胰岛素抵抗、组织学特征和持续病毒学应答的相关性。

Interferon-γ-inducible protein-10 in chronic hepatitis C: Correlations with insulin resistance, histological features & sustained virological response.

机构信息

Department of Hepatology, Regional Institute of Gastroenterology & Hepatology "Prof. Dr. Octavian Fodor"; Department of Internal Medicine, 3rd Medical Clinic, Iuliu Hatieganu University of Medicine & Pharmacy, Cluj-Napoca, Romania.

Department of Hepatology, Regional Institute of Gastroenterology & Hepatology "Prof. Dr. Octavian Fodor", Cluj-Napoca, Romania.

出版信息

Indian J Med Res. 2017 Apr;145(4):543-550. doi: 10.4103/ijmr.IJMR_1410_14.

DOI:10.4103/ijmr.IJMR_1410_14
PMID:28862188
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5663170/
Abstract

BACKGROUND & OBJECTIVES: One of the multiple factors contributing to virological response in chronic hepatitis C (CHC) is interferon-gamma-inducible protein-10 (IP-10). Its level reflects the status of interferon-stimulated genes, which in turn is associated with virological response to antiviral therapy. The aim of this study was to evaluate the role of serum IP-10 levels on sustained virological response (SVR) and the association of this parameter with insulin resistance (IR) and liver histology.

METHODS

Two hundred and three consecutive biopsy proven CHC patients were included in the study. Serum levels of IP-10 were determined using ELISA method. IR was evaluated by homeostasis model assessment-IR (HOMA-IR). Histological features were assessed invasively by liver biopsy and noninvasively using FibroTest, ActiTest and SteatoTest. Predictive factors for SVR and their interrelations were assessed.

RESULTS

A cut-off value for IP-10 of 392 pg/ml was obtained to discriminate between responders and non-responders. SVR was obtained in 107 patients (52.70%). Area under the receiver operating characteristic curve for SVR was 0.875 with a sensitivity of 91.6 per cent, specificity 74.7 per cent, positive predictive value 80.3 per cent and negative predictive value 88.7 per cent. Higher values of IP-10 were associated with increasing stages of fibrosis (P<0.01) and higher grades of inflammation (P=0.02, P=0.07) assessed morphologically and noninvasively through FibroTest and ActiTest. Significant steatosis and IR were also associated with increased levels of IP-10 (P=0.01 and P=0.02). In multivariate analysis, IP-10 levels and fibrosis stages were independently associated with SVR.

INTERPRETATION & CONCLUSIONS: Our findings showed that the assessment of serum IP-10 level could be a predictive factor for SVR and it was associated with fibrosis, necroinflammatory activity, significant steatosis and IR in patients with chronic HCV infection.

摘要

背景与目的

导致慢性丙型肝炎(CHC)病毒学应答的多种因素之一是干扰素-γ诱导蛋白-10(IP-10)。其水平反映了干扰素刺激基因的状态,而这又与抗病毒治疗的病毒学应答相关。本研究旨在评估血清 IP-10 水平对持续病毒学应答(SVR)的作用,并探讨该参数与胰岛素抵抗(IR)和肝组织学之间的关系。

方法

本研究纳入了 203 例经肝活检证实的 CHC 连续患者。采用酶联免疫吸附法(ELISA)测定血清 IP-10 水平。通过稳态模型评估-IR(HOMA-IR)评估 IR。通过肝活检进行侵袭性评估,并使用 FibroTest、ActiTest 和 SteatoTest 进行非侵袭性评估。评估 SVR 的预测因素及其相互关系。

结果

获得了区分应答者和无应答者的 IP-10 截断值为 392pg/ml。107 例患者(52.70%)获得 SVR。SVR 的受试者工作特征曲线下面积为 0.875,敏感性为 91.6%,特异性为 74.7%,阳性预测值为 80.3%,阴性预测值为 88.7%。IP-10 水平越高,纤维化分期越高(P<0.01),形态学和非侵袭性评估的炎症程度越高(P=0.02,P=0.07,通过 FibroTest 和 ActiTest)。显著的脂肪变性和 IR 也与 IP-10 水平升高相关(P=0.01 和 P=0.02)。多变量分析显示,IP-10 水平和纤维化分期与 SVR 独立相关。

解释与结论

我们的研究结果表明,血清 IP-10 水平的评估可能是 SVR 的预测因素,与慢性 HCV 感染患者的纤维化、坏死性炎症活动、显著的脂肪变性和 IR 相关。

相似文献

1
Interferon-γ-inducible protein-10 in chronic hepatitis C: Correlations with insulin resistance, histological features & sustained virological response.γ-干扰素诱导蛋白-10 与慢性丙型肝炎:与胰岛素抵抗、组织学特征和持续病毒学应答的相关性。
Indian J Med Res. 2017 Apr;145(4):543-550. doi: 10.4103/ijmr.IJMR_1410_14.
2
Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C.1型慢性丙型肝炎感染患者治疗前血清干扰素γ诱导蛋白10水平与聚乙二醇干扰素联合利巴韦林治疗持续病毒学应答的相关性
Gut. 2006 Mar;55(3):374-9. doi: 10.1136/gut.2005.074062. Epub 2005 Sep 8.
3
Association of interferon-γ-induced protein-10 serum levels with virological responses to PEG-interferon-based therapy in hepatitis C virus genotype 1 or 2 chronically infected Chinese patients.丙型肝炎病毒1型或2型慢性感染中国患者中,血清干扰素γ诱导蛋白10水平与基于聚乙二醇干扰素治疗的病毒学应答的相关性
Scand J Gastroenterol. 2014 Nov;49(11):1349-58. doi: 10.3109/00365521.2014.962609. Epub 2014 Sep 29.
4
Relationship of interferon-γ-inducible protein-10 kDa with viral response in patients with various heterogeneities of hepatitis C virus genotype-4.干扰素-γ诱导蛋白-10kDa 与丙型肝炎病毒基因型 4 不同基因型患者病毒应答的关系。
Eur J Gastroenterol Hepatol. 2013 Apr;25(4):404-10. doi: 10.1097/MEG.0b013e32835bc2cf.
5
IP-10 Serum Level in Chronic Hepatitis C Virus Patients: Relation to Fibrosis and Response to Combined Interferon/Ribavirin Therapy.慢性丙型肝炎病毒患者的IP-10血清水平:与纤维化的关系及对干扰素/利巴韦林联合治疗的反应
J Interferon Cytokine Res. 2015 Aug;35(8):649-53. doi: 10.1089/jir.2014.0193. Epub 2015 May 14.
6
Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4.脂肪细胞因子与胰岛素抵抗:埃及慢性丙型肝炎病毒基因 4 型患者对治疗反应的预测因子。
Eur J Gastroenterol Hepatol. 2013 Aug;25(8):920-5. doi: 10.1097/MEG.0b013e32835f2726.
7
Pretreatment serum interferon gamma inducible protein-10 as biomarker of fibrosis and predictor of virological response in genotype 4 hepatitis C virus infection.治疗前血清干扰素γ诱导蛋白-10作为4型丙型肝炎病毒感染中纤维化的生物标志物和病毒学反应的预测指标。
Acta Gastroenterol Belg. 2014 Dec;77(4):401-7.
8
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection.干扰素(IFN)-γ诱导蛋白10:与聚乙二醇化干扰素α-2a联合利巴韦林治疗慢性丙型肝炎病毒感染期间的组织学结果、病毒动力学及疗效的相关性
J Infect Dis. 2006 Oct 1;194(7):895-903. doi: 10.1086/507307. Epub 2006 Aug 29.
9
IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection.IP-10与丙型肝炎病毒载量、肝脏炎症及纤维化相关,并可预测HIV-HCV合并感染中丙型肝炎病毒的复发或无应答情况。
Antivir Ther. 2008;13(8):969-76.
10
Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.1型丙型肝炎病毒(HCV)感染的非糖尿病、非肝硬化患者抗病毒治疗期间胰岛素抵抗的时间进程。
Antivir Ther. 2009;14(5):631-9.

引用本文的文献

1
Interferon Upregulation Associates with Insulin Resistance in Humans.干扰素上调与人类胰岛素抵抗相关。
Curr Diabetes Rev. 2025;21(3):86-105. doi: 10.2174/0115733998294022240309105112.
2
High Abundance of genus Prevotella in the gut of perinatally HIV-infected children is associated with IP-10 levels despite therapy.肠道中普雷沃氏菌属丰度高与 IP-10 水平相关,尽管进行了治疗,但仍与围产期感染 HIV 的儿童相关。
Sci Rep. 2018 Dec 5;8(1):17679. doi: 10.1038/s41598-018-35877-4.

本文引用的文献

1
Sofosbuvir for previously untreated chronic hepatitis C infection.索磷布韦片治疗未经治疗的慢性丙型肝炎感染。
N Engl J Med. 2013 May 16;368(20):1878-87. doi: 10.1056/NEJMoa1214853. Epub 2013 Apr 23.
2
Hepatocyte growth factor and interferon-γ inducible protein-10 are related to visceral adiposity.肝细胞生长因子和干扰素-γ诱导蛋白-10 与内脏肥胖有关。
Eur J Clin Invest. 2013 Apr;43(4):369-78. doi: 10.1111/eci.12054. Epub 2013 Feb 10.
3
Patients affected by metabolic syndrome show decreased levels of circulating platelet derived growth factor (PDGF)-BB.患有代谢综合征的患者表现出循环血小板衍生生长因子 (PDGF)-BB 水平降低。
Clin Nutr. 2013 Apr;32(2):259-64. doi: 10.1016/j.clnu.2012.07.003. Epub 2012 Jul 26.
4
Serum IP-10 Levels Correlate with the Severity of Liver Histopathology in Patients Infected with Genotype-1 HCV.血清 IP-10 水平与感染 HCV 基因型 1 的患者肝组织病理学严重程度相关。
Gut Liver. 2011 Dec;5(4):506-12. doi: 10.5009/gnl.2011.5.4.506. Epub 2011 Nov 21.
5
High plasma CXCL10 levels are associated with HCV-genotype 1, and higher insulin resistance, fibrosis, and HIV viral load in HIV/HCV coinfected patients.高血浆 CXCL10 水平与 HCV 基因型 1 以及 HIV/HCV 合并感染患者的更高胰岛素抵抗、纤维化和 HIV 病毒载量相关。
Cytokine. 2012 Jan;57(1):25-9. doi: 10.1016/j.cyto.2011.10.020. Epub 2011 Dec 3.
6
Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.代谢综合征的协调:国际糖尿病联盟流行病学与预防特别工作组、美国国立心肺血液研究所、美国心脏协会、世界心脏联盟、国际动脉粥样硬化学会以及国际肥胖研究协会的联合中期声明
Circulation. 2009 Oct 20;120(16):1640-5. doi: 10.1161/CIRCULATIONAHA.109.192644. Epub 2009 Oct 5.
7
Metabolic syndrome, insulin resistance and adiponectin level in patients with chronic hepatitis C.慢性丙型肝炎患者的代谢综合征、胰岛素抵抗与脂联素水平
J Gastrointestin Liver Dis. 2008 Jun;17(2):147-54.
8
The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.趋化因子在慢性丙型肝炎病毒感染中作为炎症介质的作用。
J Viral Hepat. 2007 Oct;14(10):675-87. doi: 10.1111/j.1365-2893.2006.00838.x.
9
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection.IP-10可预测1型丙型肝炎病毒感染的难治性患者的病毒反应和治疗结果。
Hepatology. 2006 Dec;44(6):1617-25. doi: 10.1002/hep.21407.
10
Insulin resistance and hepatitis C.胰岛素抵抗与丙型肝炎。
World J Gastroenterol. 2006 Nov 28;12(44):7075-80. doi: 10.3748/wjg.v12.i44.7075.